105 related articles for article (PubMed ID: 14684151)
1. Evolutionarily conserved expression pattern and trans-regulating activity of Xenopus p51/p63.
Tomimori Y; Katoh I; Kurata S; Okuyama T; Kamiyama R; Ikawa Y
Biochem Biophys Res Commun; 2004 Jan; 313(2):230-6. PubMed ID: 14684151
[TBL] [Abstract][Full Text] [Related]
2. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
[TBL] [Abstract][Full Text] [Related]
3. Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia.
Yamaguchi H; Inokuchi K; Sakuma Y; Dan K
Leukemia; 2001 Nov; 15(11):1729-34. PubMed ID: 11681414
[TBL] [Abstract][Full Text] [Related]
4. p51/p63 Controls subunit alpha3 of the major epidermis integrin anchoring the stem cells to the niche.
Kurata S; Okuyama T; Osada M; Watanabe T; Tomimori Y; Sato S; Iwai A; Tsuji T; Ikawa Y; Katoh I
J Biol Chem; 2004 Nov; 279(48):50069-77. PubMed ID: 15361520
[TBL] [Abstract][Full Text] [Related]
5. p53CP is p51/p63, the third member of the p53 gene family: partial purification and characterization.
Tan M; Bian J; Guan K; Sun Y
Carcinogenesis; 2001 Feb; 22(2):295-300. PubMed ID: 11181451
[TBL] [Abstract][Full Text] [Related]
6. TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53.
Li N; Li H; Cherukuri P; Farzan S; Harmes DC; DiRenzo J
Oncogene; 2006 Apr; 25(16):2349-59. PubMed ID: 16331262
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization and expression of p63 isoforms in human keloids.
De Felice B; Wilson RR; Nacca M; Ciarmiello LF; Pinelli C
Mol Genet Genomics; 2004 Aug; 272(1):28-34. PubMed ID: 15248062
[TBL] [Abstract][Full Text] [Related]
8. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.
Shimada A; Kato S; Enjo K; Osada M; Ikawa Y; Kohno K; Obinata M; Kanamaru R; Ikawa S; Ishioka C
Cancer Res; 1999 Jun; 59(12):2781-6. PubMed ID: 10383130
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51.
Senoo M; Tsuchiya I; Matsumura Y; Mori T; Saito Y; Kato H; Okamoto T; Habu S
Br J Cancer; 2001 May; 84(9):1235-41. PubMed ID: 11336476
[TBL] [Abstract][Full Text] [Related]
10. SSRP1 functions as a co-activator of the transcriptional activator p63.
Zeng SX; Dai MS; Keller DM; Lu H
EMBO J; 2002 Oct; 21(20):5487-97. PubMed ID: 12374749
[TBL] [Abstract][Full Text] [Related]
11. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species.
Ellisen LW; Ramsayer KD; Johannessen CM; Yang A; Beppu H; Minda K; Oliner JD; McKeon F; Haber DA
Mol Cell; 2002 Nov; 10(5):995-1005. PubMed ID: 12453409
[TBL] [Abstract][Full Text] [Related]
12. Mutation and expression of the p51 gene in human lung cancer.
Tani M; Shimizu K; Kawahara C; Kohno T; Ishimoto O; Ikawa S; Yokota J
Neoplasia; 1999 Apr; 1(1):71-9. PubMed ID: 10935472
[TBL] [Abstract][Full Text] [Related]
13. Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.
Ghioni P; Bolognese F; Duijf PH; Van Bokhoven H; Mantovani R; Guerrini L
Mol Cell Biol; 2002 Dec; 22(24):8659-68. PubMed ID: 12446784
[TBL] [Abstract][Full Text] [Related]
14. DeltaNp63 antagonizes p53 to regulate mesoderm induction in Xenopus laevis.
Barton CE; Tahinci E; Barbieri CE; Johnson KN; Hanson AJ; Jernigan KK; Chen TW; Lee E; Pietenpol JA
Dev Biol; 2009 May; 329(1):130-9. PubMed ID: 19272371
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
16. Differential recognition of response elements determines target gene specificity for p53 and p63.
Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
[TBL] [Abstract][Full Text] [Related]
17. p63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms.
Okuyama T; Kurata S; Tomimori Y; Fukunishi N; Sato S; Osada M; Tsukinoki K; Jin HF; Yamashita A; Ito M; Kobayashi S; Hata RI; Ikawa Y; Katoh I
Oncogene; 2008 Jan; 27(3):308-17. PubMed ID: 17637751
[TBL] [Abstract][Full Text] [Related]
18. Expression profiles and functional implications of p53-like transcription factors in thymic epithelial cell subtypes.
Kikuchi T; Ichimiya S; Kojima T; Crisa L; Koshiba S; Tonooka A; Kondo N; Van Der Saag PT; Yokoyama S; Sato N
Int Immunol; 2004 Jun; 16(6):831-41. PubMed ID: 15126418
[TBL] [Abstract][Full Text] [Related]
19. p63 antagonizes Wnt-induced transcription.
Drewelus I; Göpfert C; Hippel C; Dickmanns A; Damianitsch K; Pieler T; Dobbelstein M
Cell Cycle; 2010 Feb; 9(3):580-87. PubMed ID: 20107313
[TBL] [Abstract][Full Text] [Related]
20. DNA-binding and transactivation activities are essential for TAp63 protein degradation.
Ying H; Chang DL; Zheng H; McKeon F; Xiao ZX
Mol Cell Biol; 2005 Jul; 25(14):6154-64. PubMed ID: 15988026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
